FDA Approves Genentech’s Gazyva for the Treatment of Lupus Nephritis

Oct 20, 2025 - 22:00
 0  1
South San Francisco, CA -- October 19, 2025 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved Gazyva (obinutuzumab) for the treatment of adult...

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0